lilly.no


lilly.no Website Info

lilly.no (Hjemmeside for Eli Lilly and Company in Norway) was registered first at 2012-04-13. It's hosted by Proceed to detail/login page. DNS looks Active and website looks Accessable. According to Google, website speed score is 0/100 and . Website looks safe for children.
lilly.no


lilly.no Website Tags

Domain Status:
✓ Active
Is Site Accessable?:
✓ Yes
SSL(https):
✓ Yes
Accessable Url:
Title:
Home | Lilly Norge
Description:
Hjemmeside for Eli Lilly and Company in Norway
Mobile Friendly?:
✓ Yes
Canonical URL:
[Not Set]

lilly.no Domain & Whois Details

Refresh
Domain Create Date:
2012-04-13
Domain Age:
13 years, 2 months, 19 days
Hosting Location:
GB - UNITED KINGDOM
Hosting Provider:
Proceed to detail/login page
IP:
78.129.253.54



lilly.no Website Speed (Desktop) Check Now

Speed analysis has not been completed yet. Our system will be checking this website soon.


lilly.no Website Safety

Refresh
Last Check Date:
6/19/2023 5:33:11 AM
Fortiguard:
Medicine
Mcafee Category:
Pharmacy
OpenDNS:
BeFirst
Cloudflare DNS:
OK
MyWot Child Safety:
99

lilly.no HTTP Headers

Refresh


lilly.no W3C HTML Validation Check Now

Last Check Date:
Errors:
Warnings:
Info:

lilly.no Similar Sites

Website
Title
Rank
Home Page | Environmental Law Institute
71,658
Bighoki288 Slot Qris 5000 Slot 88 hoki gacor Deposit via Qris 5000 gampang menang hari ini
ColdHardFootballFacts : Home
1,927,968
Eli.ubc.ca - University of British Columbia Engineering Information
Home | Lilly Italia
9,423,190

lilly.no Site Keywords

Eli
Eli Lilly
eli lilly oslo
Eli Lily
Lilly Norge
terapiområder

lilly.no Site H Tags

Check Now

lilly.no Sites with Same Names

Website
Title
Rank
Home | Lilly Italia
9,423,190
LILLY Brudekjoler, Festkjoler og Konfirmationskjoler
8,731,683
Home | Lilly Schweiz
8,582,488
Lilly.com | Pharmacare Solutions and Innovation
854
Home | Lilly New Zealand
7,916,187
Lilly.eu - Your Source for Healthcare & Pharmaceutical Insights
6,039,965
Home | Lilly Ireland
5,924,987
Home | Lilly Nederland
4,676,188
Inicio | Lilly España
3,430,787
Lilly Polska
34,301,512
首頁 I 台灣禮來
32,667,014
Lilly Japan | Pharmaceutical Innovation & Healthcare Solutions
2,992,682
Home | Lilly Australia
2,799,973
Lilly Slovensko
26,765,061
Lilly.fr - Votre destination beauté et soins en ligne
2,059,254
Все для маникюра - купить все для маникюра в Киеве и Украине | Заказать все для ногтей в интернет магазине все для маникюра lillyshop
17,146,059
Lilly.rs - Leading Healthcare Solutions in Serbia
1,629,650
Home | Lilly Canada
1,449,807
Lilly.pk - Premium Women's Fashion & Accessories in Pakistan
0
Lilly.com | Eli Lilly and Company
Home | Lilly UK
Principal | Lilly LATAM
Eli Lilly do Brasil
BIG-IP logout page
Home | Lilly India
Компанія Елі Ліллі в Україні
Página inicial | Lilly Portugal
Eli Lilly and Company-Home
Eli Lilly and Company-Home

What is SitesDB?

SitesDB is one of the largest databases of websites and domain names on the internet, with over 40 million entries and growing. For more than 12 years, we've been manually verifying and updating website and domain details, combining human expertise with AI-powered systems to ensure the accuracy and relevance of our data.

At SitesDB, we provide in-depth technical and useful information about websites and domains, including:

  • Website meta tags
  • Domain & WHOIS data
  • General backlink and ranking statistics
  • Social media engagement stats
  • Root page speed insights
  • Website content and HTML resources
  • Website safety and security details, sourced from multiple trusted security providers
  • HTTP headers analysis
  • HTML validation reports
  • Lists of similar websites and competitors
  • Website keyword analysis, including top traffic-driving keywords
  • Heading structure (H tags) breakdown
  • Domain variations across different TLDs (Top-Level Domains)

In addition to this data, SitesDB offers a suite of website analysis tools — including Chrome CRUX, Google Lighthouse, and our own AI-enhanced algorithms — to help identify alternative websites, direct competitors, and similar sites, all continuously refined through both automated systems and human review.